147 related articles for article (PubMed ID: 34607987)
1. Synthesis, structure and in vitro biological properties of a new copper(II) complex with 4-{[3-(pyridin-2-yl)-1H-pyrazol-1-yl]methyl}benzoic acid.
Li X; Niu M; Wang A; Lu L; Englert U; Feng S; Zhang L; Yuan C
Acta Crystallogr C Struct Chem; 2021 Oct; 77(Pt 10):641-648. PubMed ID: 34607987
[TBL] [Abstract][Full Text] [Related]
2. In situ synthesis of mononuclear copper(II) complexes of the new tridentate ligand bis[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]amine.
Yu F
Acta Crystallogr C; 2011 Oct; 67(Pt 10):m331-4. PubMed ID: 21979969
[TBL] [Abstract][Full Text] [Related]
3. Copper(II) bromide, nitrate and perchlorate complexes with sterically demanding N-(6-methylpyridin-2-yl)acetamide ligands.
Smolentsev AI
Acta Crystallogr C Struct Chem; 2017 Aug; 73(Pt 8):613-619. PubMed ID: 28776512
[TBL] [Abstract][Full Text] [Related]
4. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
5. A two-dimensional mixed-valence Cu(II)/Cu(I) coordination polymer constructed from 2-(pyridin-3-yl)-1H-imidazole-4,5-dicarboxylate.
Zhang LY; Lu LP; Feng SS
Acta Crystallogr C Struct Chem; 2016 Aug; 72(Pt 8):652-7. PubMed ID: 27487340
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, crystal structures and characterizations of three new copper(II) complexes including anti-inflammatory diclofenac.
Hamamci Alisir S; Dege N; Tapramaz R
Acta Crystallogr C Struct Chem; 2019 Apr; 75(Pt 4):388-397. PubMed ID: 30957784
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and "scorpionate" ligands with "in vitro" superoxide scavenging activity.
Santini C; Pellei M; Lobbia GG; Fedeli D; Falcioni G
J Inorg Biochem; 2003 Apr; 94(4):348-54. PubMed ID: 12667706
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
10. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
11. Copper(I)/O2 chemistry with imidazole containing tripodal tetradentate ligands leading to mu-1,2-peroxo-dicopper(II) species.
Lee Y; Park GY; Lucas HR; Vajda PL; Kamaraj K; Vance MA; Milligan AE; Woertink JS; Siegler MA; Narducci Sarjeant AA; Zakharov LN; Rheingold AL; Solomon EI; Karlin KD
Inorg Chem; 2009 Dec; 48(23):11297-309. PubMed ID: 19886646
[TBL] [Abstract][Full Text] [Related]
12. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
[TBL] [Abstract][Full Text] [Related]
13. Three novel topologically different metal-organic frameworks built from 3-nitro-4-(pyridin-4-yl)benzoic acid.
Qin T; Zhang S; Wang Y; Hou T; Zhu D; Jing S
Acta Crystallogr C Struct Chem; 2019 Feb; 75(Pt 2):150-160. PubMed ID: 30720453
[TBL] [Abstract][Full Text] [Related]
14. Chloridobis[2-(1,5-dimethyl-1H-pyrazol-3-yl-κN)-1-methyl-1H-imidazole-κN]copper(II) chloride methanol hemisolvate tetra-hydrate.
El Ghayati L; Tjiou el M; El Ammari L
Acta Crystallogr Sect E Struct Rep Online; 2010 Jan; 66(Pt 2):m134-5. PubMed ID: 21579617
[TBL] [Abstract][Full Text] [Related]
15. Bis[2-(amino-meth-yl)pyridine-κN,N']bis-(thio-cyanato-κN)copper(II).
Karan NK; Chan KT; Lee HM
Acta Crystallogr Sect E Struct Rep Online; 2009 Apr; 65(Pt 5):m525. PubMed ID: 21583767
[TBL] [Abstract][Full Text] [Related]
16. Copper(II) complexes with 2NO and 3N donor ligands: synthesis, structures and chemical nuclease and anticancer activities.
Rajarajeswari C; Loganathan R; Palaniandavar M; Suresh E; Riyasdeen A; Akbarsha MA
Dalton Trans; 2013 Jun; 42(23):8347-63. PubMed ID: 23612925
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of protein tyrosine phosphatases by quinquedentate binuclear copper complexes: synthesis, characterization and biological activities.
Wang Q; Zhu M; Lu L; Yuan C; Xing S; Fu X
Dalton Trans; 2011 Dec; 40(48):12926-34. PubMed ID: 22027948
[TBL] [Abstract][Full Text] [Related]
18. Methanol[1-(methoxymethanimidoyl)-2-(pyridin-2-ylmethyl)guanidine]bis(perchlorato)copper(II).
Meenongwa A; Chaveerach U; Blake AJ
Acta Crystallogr C; 2012 Jun; 68(Pt 6):m143-6. PubMed ID: 22669184
[TBL] [Abstract][Full Text] [Related]
19. H2O2-reactivity of copper(II) complexes supported by tris[(pyridin-2-yl)methyl]amine ligands with 6-phenyl substituents.
Kunishita A; Kubo M; Ishimaru H; Ogura T; Sugimoto H; Itoh S
Inorg Chem; 2008 Dec; 47(24):12032-9. PubMed ID: 18998628
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of chlorido-{1-(2,3-dimethyl-5-oxido-1-phenyl-1H-pyrazol-2-ium-4-yl-κO)-2-[3-methyl-5-oxo-1-phenyl-4,5-di-hydro-1H-pyrazol-4-yl-idene-κO]hydrazin-1-ido-κN (1)}copper(II) from laboratory X-ray powder data.
Kovalchukova O; Nguen V; Strashnova S; Kuznetsov D; Berikashvili T
Acta Crystallogr E Crystallogr Commun; 2015 Feb; 71(Pt 2):124-7. PubMed ID: 25878798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
